Coverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 27, 2026. Only the current version of each report is used.
38,130 report citations, newest first.
SANOFI U.S. SERVICES, INC. · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$60,000
Paid to lobbying firm
CitesS. 1040· this member:Sponsored
Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SANOFI U.S. SERVICES, INC. · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$60,000
Paid to lobbying firm
CitesS. 1041· this member:Sponsored
Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMD SERONO INC · lobbying firm or registrant: EMD SERONO, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$730,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
P.L. 119-21 (H.R. 1): One Big Beautiful Bill Act; relating to Title VII, Subtitle B H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period betw…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMD SERONO INC · lobbying firm or registrant: EMD SERONO, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$730,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
P.L. 119-21 (H.R. 1): One Big Beautiful Bill Act; provisions related to Title VII, Subtitle B H.R. 946: Orphan CURES Act; all provisions H.R. 2214: DRUG Act; all provisions H.R. 4…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMD SERONO INC · lobbying firm or registrant: EMD SERONO, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$730,000
Spent on own lobbying
CitesS. 3345· this member:Cosponsored
…re Middlemen Act; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX S. 1862: Orphan CURES Act; all provisions S. 3345: PBM Price Transparency and Accountability Act; all provisions Executive Order #14216: Expanding Access to In Vitro Fertilization; all provisions of the order…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMD SERONO INC · lobbying firm or registrant: EMD SERONO, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$730,000
Spent on own lobbying
CitesS. 1071· this member:SponsoredRecorded votes on 3 roll calls
…tary Families Act; all provisions H.R. 8800: National Defense Authorization Act for Fiscal Year 2027; provisions related to Military access to infertility care S. 1071: National Defense Authorization Act for Fiscal Year 2026; provisions related to Military access to infertility care S. 2296: National Defense Authorization Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMD SERONO INC · lobbying firm or registrant: EMD SERONO, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$730,000
Spent on own lobbying
CitesS. 2296· this member:Recorded votes on 12 roll calls
…Military access to infertility care S. 1071: National Defense Authorization Act for Fiscal Year 2026; provisions related to Military access to infertility care S. 2296: National Defense Authorization Act for Fiscal Year 2026; provisions related to Military access to infertility care S. 4784: National Defense Authorization Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EMD SERONO INC · lobbying firm or registrant: EMD SERONO, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$730,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
…Military access to infertility care S. 2296: National Defense Authorization Act for Fiscal Year 2026; provisions related to Military access to infertility care S. 4784: National Defense Authorization Act for Fiscal Year 2027; provisions related to Military access to infertility care Discussions related to Military access to i…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
INVEST IN EDUCATION COALITION · lobbying firm or registrant: MICHAEL BEST STRATEGIES LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$20,000
Paid to lobbying firm
CitesH.R. 1· this member:Recorded votes on 44 roll calls
Issues related to primary education, regulations related to the scholarship tax credit provision in P.L. 119-21 (H.R. 1).
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$40,000
Paid to lobbying firm
CitesS. 1040· this member:Sponsored
Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$40,000
Paid to lobbying firm
CitesS. 1041· this member:Sponsored
Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PFIZER, INC. · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$60,000
Paid to lobbying firm
CitesS. 1040· this member:Sponsored
Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PFIZER, INC. · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$60,000
Paid to lobbying firm
CitesS. 1041· this member:Sponsored
Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
STARKEY LABORATORIES, INC. · lobbying firm or registrant: DUDDINGTON GLOBAL STRATEGIES LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$20,000
Paid to lobbying firm
CitesH.R. 1968· this member:Recorded votes on 6 roll calls
…s matters, including National Defense Authorization Act (NDAA) for Fiscal Year 2025 (PL 118-159), Full Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968), National Defense Authorization Act (NDAA) for Fiscal Year 2026 (no bill number).
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
STARKEY LABORATORIES, INC. · lobbying firm or registrant: DUDDINGTON GLOBAL STRATEGIES LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Veterans
$20,000
Paid to lobbying firm
CitesH.R. 1968· this member:Recorded votes on 6 roll calls
…s matters, including National Defense Authorization Act (NDAA) for Fiscal Year 2025 (PL 118-159), Full Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968), National Defense Authorization Act (NDAA) for Fiscal Year 2026 (no bill number).
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CALIFORNIA RECYCLING ALLIANCE · lobbying firm or registrant: RIDGELINE ADVOCACY GROUP LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$40,000
Paid to lobbying firm
CitesS. 4784· this member:Recorded vote on 1 roll call
H.R. 8800, FY27 National Defense Authorization Act S.4784, FY27 National Defense Authorization Act Issues related to defense industrial base supply chain, scrap metal recycling, military readiness, and critical minera…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GRAIL, INC. · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$60,000
Paid to lobbying firm
CitesH.R. 7148· this member:Recorded votes on 8 roll calls
Issues related to cancer screening, including the implementation of Section 6221 of H.R.7148 - Consolidated Appropriations Act, 2026, PL 119-75.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL HOCKEY LEAGUE · lobbying firm or registrant: NATIONAL HOCKEY LEAGUE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Sports/Athletics
$150,000
Spent on own lobbying
CitesS. 4668· this member:Recorded votes on 11 roll calls
Issues concerning the Sports Broadcasting Act; Issues concerning the Protecting College Sports Act (S. 4668); Issues concerning the Miracle on Ice Congressional Gold Medal Act; Senate Resolutions Congratulating the Carolina Hurricanes on winning the Stanley Cup; Foll…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GENENTECH, INC. · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$60,000
Paid to lobbying firm
CitesS. 1040· this member:Sponsored
Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GENENTECH, INC. · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$60,000
Paid to lobbying firm
CitesS. 1041· this member:Sponsored
Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GENENTECH, INC. · lobbying firm or registrant: MARSHALL & POPP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$60,000
Paid to lobbying firm
CitesH.R. 7148· this member:Recorded votes on 8 roll calls
…ated to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including Division J of H.R.7148 - Consolidated Appropriations Act, 2026, PL 119-75. Issues related to the 340B program.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VISA · lobbying firm or registrant: WILLIAMS AND JENSEN, PLLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Financial Institutions/Investments/Securities
$50,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
…elating to the Credit Card Competition Act. S. 3623 & H.R. 7035. S. 394. PL 119-27 Guiding and Establishing National Innovation for US Stablecoin (GENIUS) Act. H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
HOPE THROUGH HOUSING FOUNDATION · lobbying firm or registrant: GRAYROBINSON PA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
CitesH.R. 6644· this member:Recorded votes on 9 roll calls
Federal funding to support expanded residential services for residents of affordable housing communities. H.R.6644, 21st Century ROAD to Housing Act, provisions related to affordable housing. H.R. 4874, Affordable Housing Resident Services Act, all provisions.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
PLANET LABS PBC · lobbying firm or registrant: PLANET LABS PBC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Aerospace
$390,000
Spent on own lobbying
CitesS. 1437· this member:Cosponsored
…ommercial space activities; Wireless spectrum use for space activities; NASA programs; H.R. 2600, the ASCEND Act - all provisions related to satellite imagery; S. 1437, the ASCEND Act - all provisions related to satellite imagery; S. 933, NASA Transition Authorization Act of 2025 - all provisions related to satellite imagery;…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PLANET LABS PBC · lobbying firm or registrant: PLANET LABS PBC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$390,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
Satellite issues; Geospatial imagery; Defense programs and budget for commercial remote sensing; H.R. 8800, National Defense Authorization Act for FY27; S. 4784, National Defense Authorization Act for FY27; H.R. 9495, Department of Defense Appropriations Act, 2027.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
